These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

689 related items for PubMed ID: 23568722

  • 1. [Immunophenotyping and molecular genetic analysis of diffuse large B-cell lymphoma].
    Han YS, Xue YQ, Yang HY, Zhang J, Pan JL.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):143-7. PubMed ID: 23568722
    [Abstract] [Full Text] [Related]

  • 2. Clinical Significance of BCL2, C-MYC, and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients.
    Ting CY, Chang KM, Kuan JW, Sathar J, Chew LP, Wong OJ, Yusuf Y, Wong L, Samsudin AT, Pana MNBM, Lee SK, Gopal NSR, Puri R, Ong TC, Bahari SK, Goh AS, Teoh CS.
    Int J Med Sci; 2019 Apr; 16(4):556-566. PubMed ID: 31171907
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation.
    Hori Y, Yamamoto H, Nozaki Y, Torisu T, Fujiwara M, Taguchi K, Nishiyama K, Nakamura S, Kitazono T, Oda Y.
    Hum Pathol; 2020 Feb; 96():67-78. PubMed ID: 31734190
    [Abstract] [Full Text] [Related]

  • 5. BCL2 positive and BCL6 negative diffuse large B cell lymphoma patients benefit from R-CHOP therapy irrespective of germinal and non germinal center B cell like subtypes.
    Jovanovic MP, Mihaljevic B, Jakovic L, Martinovic VC, Fekete MD, Andjelic B, Antic D, Bogdanovic A, Boricic N, Terzic T, Jelicic J, Milenkovic S.
    J BUON; 2015 Feb; 20(3):820-8. PubMed ID: 26214636
    [Abstract] [Full Text] [Related]

  • 6. Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.
    van Imhoff GW, Boerma EJ, van der Holt B, Schuuring E, Verdonck LF, Kluin-Nelemans HC, Kluin PM.
    J Clin Oncol; 2006 Sep 01; 24(25):4135-42. PubMed ID: 16943530
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.
    Akyurek N, Uner A, Benekli M, Barista I.
    Cancer; 2012 Sep 01; 118(17):4173-83. PubMed ID: 22213394
    [Abstract] [Full Text] [Related]

  • 8. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.
    Nakamura S, Ye H, Bacon CM, Goatly A, Liu H, Kerr L, Banham AH, Streubel B, Yao T, Tsuneyoshi M, Savio A, Takeshita M, Dartigues P, Ruskoné-Fourmestraux A, Matsumoto T, Iida M, Du MQ.
    Clin Cancer Res; 2008 May 15; 14(10):3002-10. PubMed ID: 18445693
    [Abstract] [Full Text] [Related]

  • 9. Immunophenotypic and genetic characteristics of diffuse large B-cell lymphoma in Taiwan.
    Chang ST, Chen SW, Ho CH, Kuo CC, Sakata S, Takeuchi K, Chuang SS.
    J Formos Med Assoc; 2016 Nov 15; 115(11):961-967. PubMed ID: 27773559
    [Abstract] [Full Text] [Related]

  • 10. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
    Chen M, Yang JL, Zhao S, Liu WP, Li GD, Ye YX, Yan JQ, Zhang WY.
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec 08; 47(12):920-925. PubMed ID: 30522172
    [Abstract] [Full Text] [Related]

  • 11. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
    Pillai RK, Sathanoori M, Van Oss SB, Swerdlow SH.
    Am J Surg Pathol; 2013 Mar 08; 37(3):323-32. PubMed ID: 23348205
    [Abstract] [Full Text] [Related]

  • 12. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
    Staiger AM, Ziepert M, Horn H, Scott DW, Barth TFE, Bernd HW, Feller AC, Klapper W, Szczepanowski M, Hummel M, Stein H, Lenze D, Hansmann ML, Hartmann S, Möller P, Cogliatti S, Lenz G, Trümper L, Löffler M, Schmitz N, Pfreundschuh M, Rosenwald A, Ott G, German High-Grade Lymphoma Study Group.
    J Clin Oncol; 2017 Aug 01; 35(22):2515-2526. PubMed ID: 28525305
    [Abstract] [Full Text] [Related]

  • 13. [Mechanism and clinical significance of anti-apoptotic gene bcl-2 expression in diffuse large B-cell lymphoma].
    Zeng LP, Wen YL, Ma Y, Wang GQ, Li Y, Wang J, Xu LL, Zhang XM.
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun 01; 40(6):377-81. PubMed ID: 21914345
    [Abstract] [Full Text] [Related]

  • 14. Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.
    Copie-Bergman C, Gaulard P, Leroy K, Briere J, Baia M, Jais JP, Salles GA, Berger F, Haioun C, Tilly H, Emile JF, Banham AH, Mounier N, Gisselbrecht C, Feugier P, Coiffier B, Molina TJ.
    J Clin Oncol; 2009 Nov 20; 27(33):5573-9. PubMed ID: 19786664
    [Abstract] [Full Text] [Related]

  • 15. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.
    Yoon SO, Jeon YK, Paik JH, Kim WY, Kim YA, Kim JE, Kim CW.
    Histopathology; 2008 Aug 20; 53(2):205-17. PubMed ID: 18752503
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
    Borovecki A, Korać P, Nola M, Ivanković D, Jaksić B, Dominis M.
    Croat Med J; 2008 Oct 20; 49(5):625-35. PubMed ID: 18925696
    [Abstract] [Full Text] [Related]

  • 17. Characterization of de novo diffuse large B-cell lymphoma with a translocation of c-myc and immunoglobulin genes.
    Kikuchi A, Nakamura N, Kuze T, Sasaki Y, Abe M, Ohno H, Akasaka T, Nakamura S, Ohshima K, Ando K.
    Leuk Res; 2008 Aug 20; 32(8):1176-82. PubMed ID: 18460403
    [Abstract] [Full Text] [Related]

  • 18. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
    Nosrati A, Monabati A, Sadeghipour A, Radmanesh F, Safaei A, Movahedinia S.
    Ann Hematol; 2019 Jan 20; 98(1):169-173. PubMed ID: 30306208
    [Abstract] [Full Text] [Related]

  • 19. MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified.
    Yan LX, Liu YH, Luo DL, Zhang F, Cheng Y, Luo XL, Xu J, Cheng J, Zhuang HG.
    PLoS One; 2014 Jan 20; 9(8):e104068. PubMed ID: 25090026
    [Abstract] [Full Text] [Related]

  • 20. Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell lymphoma.
    Durnick DK, Law ME, Maurer MJ, Natkunam Y, Levy R, Lossos IS, Kurtin PJ, McPhail ED.
    Am J Clin Pathol; 2010 Aug 20; 134(2):278-81. PubMed ID: 20660332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.